Operative Versus Non Operative Management Outcomes of Isolated Lateral Malleolar Weber B Ankle Fractures
NCT ID: NCT03625154
Last Updated: 2018-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2018-09-01
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients who decline non operative management and elect to undergo operative open reduction internal fixation with plates and screws will comprise an operative observational cohort.
All patients will be followed for a total of 12 months from the time of injury. Clinical outcomes will be based on radiographic monitoring for ankle mortise congruency, as well as standardized SF-36 and AOFAS questionnaire scores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Versus Conservative Treatment of Weber B1 Fracture: Functional Outcome Using Gait Analysis
NCT03539029
Analysis of Medial Clear Space Widening in Weber B Ankle Fractures
NCT07028944
Weight-bearing Radiographs to Evaluate Stability in Ankles With Isolated Weber Type B Fractures.
NCT03831009
Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures
NCT05412693
A Study to Compare Two Different Managements After Ankle Surgery: Immediate and Delayed Weight-bearing.
NCT04429217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non operative control group
Patients with negative gravity stress (non-operative treatment/observational control group)
non operative management
closed reduction and splinting followed by progressive weight bearing
non operative experimental group
Patients with positive gravity stress (medial clear space \> 4 mm on initial injury pre-reduction x-rays, who undergo a reduction with closing of the medial clear space to \<4mm. Plan for nonoperative treatment of all these patients with splint and subsequent walker boot.
non operative management
closed reduction and splinting followed by progressive weight bearing
operative observational group
Patients with positive gravity stress (medial clear space \> 4 mm) who undergo a reduction with closing of the medial clear space to \<4mm who declined non-operative treatment but agree to be observed. These patients will undergo ORIF (Open Reduction and Internal Fixation) with plates and screws and function as a second observation group
ankle open reduction internal fixation
Open Reduction and Internal Fixation with plates and screws
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ankle open reduction internal fixation
Open Reduction and Internal Fixation with plates and screws
non operative management
closed reduction and splinting followed by progressive weight bearing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to provide informed consent
Exclusion Criteria
* prisoners
* psychiatric conditions that prevent ability to provide informed consent or present barriers to follow up
* insulin dependent diabetics
* patients with prior musculoskeletal issues affecting the same extremity
* Patients cannot simultaneously be enrolled in any other studies.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charles Moon
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro47932
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.